Dyadic International Inc (US: DYAI) — Healthcare · Share Price, Chart & Market Data
About: Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.76 (-6.47%)
DYAIDyadic International Inc
Loading watchlist status…
Trade DYAI now
Dyadic International Inc share price
DYAI price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 10:16 am GMT+0
DYAI price performance
-11.895%
5D
3.809%
1M
-19.385%
YTD
-37.893%
1Y
DYAI price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 10:16 am GMT+0
DYAI details
DYAI Market Signals